These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29281872)

  • 21. Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome.
    Seibel I; Cordini D; Rehak M; Hager A; Riechardt AI; Böker A; Heufelder J; Weber A; Gollrad J; Besserer A; Joussen AM
    Am J Ophthalmol; 2015 Oct; 160(4):628-36. PubMed ID: 26133249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ki67 is a better marker than PRAME in risk stratification of BAP1-positive and BAP1-loss uveal melanomas.
    Donizy P; Spytek M; Krzyziński M; Kotowski K; Markiewicz A; Romanowska-Dixon B; Biecek P; Hoang MP
    Br J Ophthalmol; 2024 Jun; 108(7):1005-1010. PubMed ID: 37734766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma.
    Egger E; Schalenbourg A; Zografos L; Bercher L; Boehringer T; Chamot L; Goitein G
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):138-47. PubMed ID: 11516863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of BAP1 and Preferentially Expressed Antigen in Melanoma (PRAME) Immunohistochemistry in Uveal Melanomas.
    Han LM; Lee KW; Uludag G; Seider MI; Afshar AR; Bloomer MM; Pekmezci M
    Mod Pathol; 2023 Apr; 36(4):100081. PubMed ID: 36788079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
    Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
    Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.
    Matatall KA; Agapova OA; Onken MD; Worley LA; Bowcock AM; Harbour JW
    BMC Cancer; 2013 Aug; 13():371. PubMed ID: 23915344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
    Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
    Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.
    Pan H; Jia R; Zhang L; Xu S; Wu Q; Song X; Zhang H; Ge S; Xu XL; Fan X
    Int J Biochem Cell Biol; 2015 Mar; 60():176-84. PubMed ID: 25582751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival after proton-beam irradiation of uveal melanomas.
    Kodjikian L; Roy P; Rouberol F; Garweg JG; Chauvel P; Manon L; Jean-Louis B; Little RE; Sasco AJ; Grange JD
    Am J Ophthalmol; 2004 Jun; 137(6):1002-10. PubMed ID: 15183783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy.
    Karlsson UL; Augsburger JJ; Shields JA; Markoe AM; Brady LW; Woodleigh R
    Ophthalmology; 1989 Mar; 96(3):382-8. PubMed ID: 2710530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas.
    Bellocq D; Roy P; Kodjikian L; Mathis T; Nguyen AM; Herault J; Rivoire M; Négrier S; Thariat J; Grange JD
    Melanoma Res; 2020 Jun; 30(3):272-278. PubMed ID: 30320630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma.
    da Costa WH; Fares AF; Bezerra SM; Morini MA; de Toledo Benigno LA; Clavijo DA; Fornazieri L; Rocha MM; da Cunha IW; de Cassio Zequi S
    Urol Oncol; 2019 Jan; 37(1):78-85. PubMed ID: 30446457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
    Kim IK; Lane AM; Gragoudas ES
    Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin Receptor Expression in Primary Uveal Melanoma.
    Hagström A; Kal Omar R; Witzenhausen H; Lardner E; Abdiu O; Stålhammar G
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma.
    van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M
    Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.
    Perez BA; Mettu P; Vajzovic L; Rivera D; Alkaissi A; Steffey BA; Cai J; Stinnett S; Dutton JJ; Buckley EG; Halperin E; Marks LB; Mruthyunjaya P; Kirsch DG
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):127-36. PubMed ID: 24613808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eyelids metastases from uveal melanoma: clinical and histopathologic features of two cases and literature review.
    Martel A; Oberic A; Moulin A; Zografos L; Hamedani M
    Eye (Lond); 2019 May; 33(5):767-771. PubMed ID: 30560912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of HSP-27, BAP1, BRAF V600E, CCR7, and PD-L1 expression in uveal melanoma on enucleated eyes and metastatic liver tumors.
    Ağın A; Kiratli H; Guresci S; Babaoglu B; Karakaya J; Soylemezoglu F
    Int J Biol Markers; 2022 Jun; 37(2):200-209. PubMed ID: 35341390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.